1. Home
  2. MAX vs OVID Comparison

MAX vs OVID Comparison

Compare MAX & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MediaAlpha Inc.

MAX

MediaAlpha Inc.

HOLD

Current Price

$12.28

Market Cap

680.7M

Sector

Industrials

ML Signal

HOLD

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$2.76

Market Cap

562.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAX
OVID
Founded
2014
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
680.7M
562.5M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
MAX
OVID
Price
$12.28
$2.76
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$12.70
$4.60
AVG Volume (30 Days)
568.2K
1.5M
Earning Date
04-29-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
25.81
3.90
EPS
0.86
N/A
Revenue
$1,113,600,000.00
$7,252,000.00
Revenue This Year
$13.42
N/A
Revenue Next Year
$8.16
$19.34
P/E Ratio
$14.30
N/A
Revenue Growth
28.78
1181.27
52 Week Low
$7.09
$1.12
52 Week High
$14.70
$3.11

Technical Indicators

Market Signals
Indicator
MAX
OVID
Relative Strength Index (RSI) 41.68 52.44
Support Level $11.59 $2.38
Resistance Level $14.08 $2.77
Average True Range (ATR) 0.50 0.15
MACD -0.10 -0.02
Stochastic Oscillator 0.66 40.91

Price Performance

Historical Comparison
MAX
OVID

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that enables insurance carriers and distributors to target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It serves as a customer acquisition channel in property and casualty insurance, health insurance, and life insurance. The company operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: